Characterization of the novel HLA-B*15:269 allele by sequencing-based typing

HLA. 2023 Dec;102(6):754-756. doi: 10.1111/tan.15211. Epub 2023 Aug 28.

Authors

Xiao-Feng Li^{1

2

3

4}, Xu Zhang^{1

2

3}, Feng-Qiu Lin^{1

2

3}, Jian-Ping Li^{1

2

3

4

5}

Affiliations

¹ Transfusion Medicine Institute, Liaoning Blood Center, Shenyang, Liaoning, China.
² Liaoning Provincial Key Laboratory for Blood Safety Research, Shenyang, Liaoning, China.
³ Key Laboratory of Blood Safety Research of Shenyang, Shenyang, Liaoning, China.
⁴ Department of Pharmacology, School of Pharmacy, China Medical University, Shenyang, Liaoning, China.
⁵ Transfusion Medicine Institute, Harbin Blood Center, Harbin, Heilongjiang, China.

PMID: 37640436
DOI: 10.1111/tan.15211

Abstract

HLA-B*15:269 differs from HLA-B*15:63 by two nucleotide substitutions in exon 3.

Keywords: HLA-B*15:269; novel allele; sequencing-based typing.

© 2023 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Alleles
Exons / genetics
Genes, MHC Class I*
HLA-B Antigens* / genetics
Histocompatibility Testing
Humans
Sequence Analysis, DNA

Substances

HLA-B Antigens